SARS-CoV-2 shedding, infectivity, and evolution in an immunocompromised adult patient

0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This study aimed to provide further insight into the evolutionary dynamics of SARS-CoV-2 by analyzing the case of a 40-year-old man who had previously undergone autologous hematopoietic stem cell transplantation due to a diffuse large B-cell lymphoma. He developed a persistent SARS-CoV-2 infection lasting at least 218 days and did not manifest a humoral immune response to the virus during this follow-up period. Whole-genome sequencing and viral cultures confirmed a persistent infection with a replication-positive virus that had undergone genetic variation for at least 196 days after symptom onset.

Cite

CITATION STYLE

APA

Mendes-Correa, M. C., de Rose Ghilardi, F., Salomão, M. C., Villas-Boas, L. S., de Paula, A. V., Paiao, H. G. O., … Witkin, S. S. (2024). SARS-CoV-2 shedding, infectivity, and evolution in an immunocompromised adult patient. Revista Do Instituto de Medicina Tropical de Sao Paulo, 66. https://doi.org/10.1590/S1678-9946202466028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free